● Recruiting

First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults

Condition: Shigella · Diarrhea · Sponsor: Inventprise Inc.

PhasePhase 1

Planned participants60

Who can joinAll sexes, 18 Years to 49 Years

Healthy volunteersYes

About this study

Phase 1 trial to evaluate the Safety and Immunogenicity of Inventprise's (IVT) Shigella-04 in Healthy Young Adults

This description comes directly from the study's public registry record.

Talk to the study team

Project Manager · 866-290-2501 · IVT514@inventprise.com

Always discuss trial participation with your own doctor first.

Locations (1)

Medpace Clinical Pharmacology Unit

Cincinnati, Ohio, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07205926